rs16997517
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000395.3(CSF2RB):c.2086C>T(p.Pro696Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0254 in 1,614,106 control chromosomes in the GnomAD database, including 1,051 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_000395.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CSF2RB | NM_000395.3 | c.2086C>T | p.Pro696Ser | missense_variant | 14/14 | ENST00000403662.8 | NP_000386.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CSF2RB | ENST00000403662.8 | c.2086C>T | p.Pro696Ser | missense_variant | 14/14 | 5 | NM_000395.3 | ENSP00000384053 | P1 | |
CSF2RB | ENST00000406230.5 | c.2104C>T | p.Pro702Ser | missense_variant | 13/13 | 1 | ENSP00000385271 |
Frequencies
GnomAD3 genomes AF: 0.0452 AC: 6873AN: 152132Hom.: 300 Cov.: 32
GnomAD3 exomes AF: 0.0265 AC: 6656AN: 251332Hom.: 199 AF XY: 0.0266 AC XY: 3615AN XY: 135856
GnomAD4 exome AF: 0.0233 AC: 34058AN: 1461856Hom.: 748 Cov.: 35 AF XY: 0.0239 AC XY: 17371AN XY: 727224
GnomAD4 genome AF: 0.0453 AC: 6892AN: 152250Hom.: 303 Cov.: 32 AF XY: 0.0438 AC XY: 3263AN XY: 74448
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 31, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 24, 2014 | Pro696Ser in exon 14 of CSF2RB: This variant is not expected to have clinical si gnificance because it has been identified in 11.4% (504/4406) of African America n chromosomes from a broad population by the NHLBI Exome Sequencing Project (htt p://evs.gs.washington.edu/EVS; dbSNP rs16997517). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at